Skip to content

Personalis, Inc. PSNL Free cash flow

Free cash flow at other companies

NeoGenomics logo
NeoGenomicsNEO
-$13.14M+56.0%
Veracyte logo
VeracyteVCYT
$32.25M+810%
Natera, Inc. logo
Natera, Inc.NTRA
$18.03M-20.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
Illumina logo
IlluminaILMN
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%

Valuation

See full
Market cap$1.19B+115%
Enterprise value$1.16B+125%
P/S18.4×+12.0×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Calculated from Personalis, Inc.’s reported figures.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s free cash flow?
Personalis, Inc. (PSNL) reported free cash flow of -$25.67M in Q1 2026.
How has Personalis, Inc.'s free cash flow changed year-over-year?
Personalis, Inc.'s free cash flow decreased by 25.4% year-over-year, from -$20.47M to -$25.67M.
What is the long-term trend for Personalis, Inc.'s free cash flow?
Over 4 years (2021 to 2025), Personalis, Inc.'s free cash flow has grown at a -0.8% compound annual growth rate (CAGR), from -$81.91M to -$79.45M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.